Axa’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-3,368
| Closed | -$33K | – | 1400 |
|
|
2017
Q2 | $33K | Sell |
3,368
-96,301
| -97% | -$944K | ﹤0.01% | 1234 |
|
|
2017
Q1 | $2.42M | Sell |
99,669
-23,264
| -19% | -$564K | 0.01% | 744 |
|
|
2016
Q4 | $3.95M | Buy |
122,933
+2,337
| +2% | +$75K | 0.02% | 627 |
|
|
2016
Q3 | $6.03M | Buy |
120,596
+70
| +0.1% | +$3.5K | 0.03% | 529 |
|
|
2016
Q2 | $5.11M | Buy |
120,526
+67,405
| +127% | +$2.86M | 0.02% | 562 |
|
|
2016
Q1 | $3.5M | Sell |
53,121
-858
| -2% | -$56.5K | 0.02% | 644 |
|
|
2015
Q4 | $3.36M | Sell |
53,979
-1,134
| -2% | -$70.5K | 0.01% | 665 |
|
|
2015
Q3 | $3.69M | Sell |
55,113
-1,166
| -2% | -$78.1K | 0.02% | 644 |
|
|
2015
Q2 | $5.48M | Hold |
56,279
| – | – | 0.02% | 572 |
|
|
2015
Q1 | $5.26M | Buy |
56,279
+35,221
| +167% | +$3.29M | 0.02% | 592 |
|
|
2014
Q4 | $1.87M | Buy |
+21,058
| New | +$1.87M | 0.01% | 809 |
|